Global brain monitoring market is anticipated to grow at a CAGR of 7.8% during the forecast period (2024-2031). The brain monitoring uses various technologies such as electroencephalogram (EEG), electromyography (EMG), cerebral blood flow monitoring, functional magnetic resonance imaging (fMRI), transcranial doppler ultrasound (TCD) ultrasound, intracranial pressure monitoring (ICP), and near-infrared spectroscopy (NIRS) to assess brain function, identify neurological conditions, and track treatment effectiveness. These tools help minimize brain damage and improve patient outcomes in research, clinical settings, and emergency departments. Furthermore, the market has seen significant growth primarily owing to increased focus on R&D by both public and private organizations and growing applications. For instance,
Browse the full report description of “Brain Monitoring Market Size, Share & Trends Analysis Report by Type (MRI Scanners, CT Scanners, EEG Devices, PET Scanners, Sleep Monitoring Devices, Cerebral Oximeters, EMG Devices, ICP Monitors, MEG Devices, and TCD Devices), by Application (Parkinson's Disease, Traumatic Brain Injury, Epilepsy, Dementia, Sleep Disorders, Stroke, Headache Disorders, and Others), and by End User (Hospitals, Diagnostic Centers, and Ambulatory Surgery Centers (ASCs) & Clinics), Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/brain-monitoring-market
In March 2024, Philips and SyntheticMR developed an AI-based quantitative brain imaging system, the Smart Quant Neuro 3D MRI machine software suite, to improve the diagnosis of disorders such as multiple sclerosis, traumatic brain injury, and dementia. The software measures brain tissues, including myelin volumes, allowing for objective assessment of traumatic brain injuries that were previously only diagnosed through symptom-based tests.
In May 2024, ChristianaCare introduced a new EEG brain monitoring program, the first of its risk patients in Delaware. This easy-to-use system measures brain electrical activity, providing vital signs for brain function, and enabling quicker diagnosis of seizures. The Ceribell point-of-care EEG monitoring system allows clinicians to triage at in just five minutes, enhancing treatment optimization.
Ceribell released its new AI algorithm, ClarityPro, which can monitor brain activity for suspected seizures and diagnose electrographic status epilepticus (ESE). The algorithm is the first acute care device to be FDA-indicated for stand-alone diagnosis and the first critical care monitoring device to secure FDA breakthrough designation and CMS new technology add-on payment reimbursement.
Market Coverage
• The market number available for – 2023-2031
• Base year- 2023
• Forecast period- 2024-2031
• Segment Covered-
o By Type
o By Application
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- GE HealthCare Technologies Inc., Integra LifeSciences Corp., Medtronic PLC, Koninklijke Philips N.V., and Masimo Corp., among others.
Key questions addressed by the report.
Global Brain Monitoring Market Report Segment
By Type
By Application
By End-User
Global Brain Monitoring Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/brain-monitoring-market